Chemotherapeutic targeting of myeloid-derived suppressor cells

Myeloid-derived suppressor cells (MDSCs), which expand in cancer-bearing hosts, contribute to the escape of malignant cells from immune destruction and impair the efficacy of immunotherapeutic interventions. We have recently demonstrated that the conventional chemotherapeutic agent doxorubicin selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Darya, Katsanis, Emmanuel, Larmonier, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960296/
https://www.ncbi.nlm.nih.gov/pubmed/24653963
http://dx.doi.org/10.4161/onci.27359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960296/
https://www.ncbi.nlm.nih.gov/pubmed/24653963
http://dx.doi.org/10.4161/onci.27359

Ejemplares similares